|
||
Infant Feed Uses |
||
Supply the daily requirement of calories, essential fatty acids, electrolytes and amino acids during parenteral nutrition fluids of patients with moderately severe catabolism, where oral or enteral nutrition is impossible, insufficient or contraindicated.
Each 100 g contains proteins (from hydrolysed casein) 14.1 g, fat (from high oleic safflower oil, soy oil, MCT oil, <2% of C. cohnii oil and M. alpina oil) 28.18 g, linoleic acid 4.069 g, carbohydrates (from corn maltodextrin, sucrose) 51.9 g, calcium 551 mg, phosphorus 394 mg, magnesium 39 mg, sodium 231 mg, potassium 620 mg, chloride 420 mg, zinc 3.94 mg, iron 9.5 mg, copper 394 mcg, manganese 42 mcg, iodine 79 mcg, selenium 9.5 mcg, vitamin A 457.8 mcg-RE, vitamin D 5.7 mcg, vitamin E 10.2 mg-TE, vitamin K1 41 mcg, vitamin C 47 mg, vitamin B1 315 mcg, vitamin B2 473 mcg, vitamin B6 315 mcg, vitamin B12 2.36 mcg, niacin (equivalent) 7.09 mg, pantothenic acid 3938 mg, folic acid 79 mcg, biotin 23.6 mcg, choline 42 mg, inositol 26 mg. Energy: 509 kCal.
Reconstitution: 1 scoop (8.7 g) to 2 fluid ounce (60 mL) water.
Some drugs, like insulin, can interfere with the body’s lipase system.
This type of interaction, however, seems to have limited clinical importance. The administration of heparin in clinical doses causes a temporary issue circulating lipoprotein lipase.
This may cause an initial increase in lipolysis of plasma, followed by a temporary reduction of elimination of triglycerides. Soybean oil has a natural content of vitamin K1, which may interfere with the therapeutic effect of coumarin derivatives, that should be tightly controlled in patients treated with these drugs.
During the administration of lipid emulsions may appear immediate reactions such as slight increase in temperature, flushing, chills, chills, loss of appetite, nausea, vomiting, dyspnea, headache, back pain, bone, chest and lumbar region, rise or fall in blood pressure (hypotension, hypertension), hypersensitivity reactions. (anaphylactic reactions, skin rashes). Flushing or bluish skin may occur as a side effect due to the reduced oxygen content in the blood (cyanosis). the appearance of such events the infusion should be interrupted or if the case, continued with a lower dose. must be paid particular attention to the possible occurrence of an overload syndrome.
It may occur as a result of genetically determined metabolic conditions that vary from individual to individual and may occur in relation to previous diseases, administration at different speeds and at different doses. An overload syndrome has the following symptoms: enlarged liver (hepatomegaly ) with or without jaundice, enlarged spleen (splenomegaly), fatty infiltration of organs, abnormal liver function, anemia, reduced white blood cells (leukopenia), decreased platelet (thrombocytopenia), bleeding diathesis and hemorrhage, alteration or loss of some coagulation factors (bleeding time, clotting time, prothrombin time, etc..), fever, hyperlipidemia, headache, stomach pain, fatigue.
This product should not be administered under the following conditions: - amino acid metabolism disorder - disorders of lipid metabolism - hyperkalemia, hypernatremia, - metabolism unstable (eg.: Severe postoperative or posttraumatic stress metabolic disorders, diabetic metabolic condition stabilized, coma of unknown origin) - hyperglycemia unresponsive to insulin doses up to 6 units of insulin per hour - acidosis - intrahepatic cholestasis - severe hepatic impairment - severe renal failure - heart failure manifests - worsening haemorrhagic diathesis, - stages of acute myocardial infarction and stroke - acute thromboembolic episodes, fat embolism - a known hypersensitivity to proteins of the ’egg or soy, peanut oil or any of the excipients.should not be used in infants and children younger than two years. Contra general parenteral nutrition are: - unstable circulatory state with imminent danger to life (states of collapse and shock) - inadequate dietary oxygen phone, - states of hydration - electrolyte balance disorders - acute pulmonary edema, congestive heart failure.
Infant Feed
List of Infant Feed substitutes (brand and generic names) | Sort by popularity |
Unit description / dosage (Manufacturer) | Price, USD |
Humana Sinelac (Italy) | |
Infasoy (South Africa) | |
Karicare AR (Australia, New Zealand) | |
Karicare De Lact Infant (New Zealand) | |
Karicare Goat Milk (Australia, New Zealand) | |
Karicare Nutrilon (Australia) | |
Karicare soy (Australia) | |
Karicare Soya (New Zealand) | |
Ketonex (India) | |
Ketonex 2% SHAMPOO / 50ml (Zytras) | $ 1.57 |
2 % x 50ml (Zytras) | $ 1.57 |
KETONEX shampoo 2 % x 50ml (Zytras) | $ 1.57 |
Lacto Pregomine (France) | |
Lactopregomine (France) | |
Laits Galliasec (France) | |
Materna Tsimchit (Israel) | |
MCT Pepdite (United Kingdom, Ireland) | |
Mellin AD (Italy) | |
Mellin AR (Italy) | |
Mellin HA (Italy) | |
Mellin Polilat (Italy) | |
Miltina HA (Portugal) | |
Miltina IPO (Italy) | |
Milumel AR (France) | |
Milumel HA (France) | |
Milumil (Portugal) | |
Milupa aptamil ar (Italy) | |
Milupa Aptamil HA (Italy) | |
Milupa aptamil soya (Italy) | |
Milupa cystilac (Poland) | |
Milupa Milumil AR (Italy) | |
Modilac AR (France) | |
Modilac HA (France) | |
Modilac sans Lactose (France) | |
Multisoy (Italy) | |
NAN (Brazil) | |
Nan 25 mg Injection (Wintech Pharmaceuticals) | $ 0.95 |
Nan 50 mg Injection (Wintech Pharmaceuticals) | $ 1.51 |
Nan AR (Mexico, Argentina, Venezuela) | |
NAN HA (Vietnam) | |
Nan HA 1 Box 400 g (Nestle) | |
NAN HA / AR | |
Nan lactose free (Thailand, Indonesia) | |
Nativa HA (Italy) | |
Neo-Soyal (Italy) | |
See 213 substitutes for Infant Feed |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|